Enhanced Laboratory Safety with Instant Liquid Waste Disposal Autoclaves
Jan 17 2023
Autoclaving hazardous used liquids provides the ultimate method for waste sterilisation, but is not without its flaws. To run efficiently, an autoclave must be run with a full load, which in turn requires liquid biohazards to be stored until there is sufficient quantity to fill an autoclave chamber, presenting a risk of spillage. Once collected, a manual handling risk is presented in lifting the many bottles of liquid waste into the autoclave. Finally, after sterilisation, removal of the hot waste from the autoclave provides the same manual handling risk, but now with the operators impeded by cumbersome heatproof personal protective equipment to mitigate the burn risks posed by the now sterile liquid.
The AstellBio Sink is a liquid waste autoclave that removes all these hazards. Laboratory staff can pour liquids directly into the device as soon as they become waste – reducing the timeframe in which waste could be spilled –, and in the quantity that they are produced in – minimising the volume and mass of the load, and thereby decreasing its manual handling risk. Once autoclaved, the liquid waste is despatched automatically to the drain, thereby removing any further stages of manual interaction, and removing the lifting and burn risks.
“The AstellBio Sink provides a simple method of validatable liquid waste sterilisation.” said Astell’s Sales & Marketing Director, Paul Birchmore. “Through its use, a simpler, safer method of liquid waste management can help protect organisations and their staff.” AstellBio will be discussing the AstellBio Sink on Stand Z2.L18 at Medlab Middle East this month.
More information online
Buyers Guide - Major producers of analytical equipment who wish to introduce and sell their products to buyers in science and industry - Over 1,000 products and services that these companys man...
View all digital editions
Jan 17 2024 Birmingham, UK
Jan 24 2024 Tokyo, Japan
Jan 29 2024 Dubai, UAE
Jan 31 2024 Tokyo, Japan
Feb 03 2024 Boston, MA, USA